News

3D illustration of the novel coronavirus.
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S… Learn more
POSTED: 5/4/2020
Logo AACR Virtual Annual Meeting I: April 27-28, 2020
Updated: July 9, 2020 NCI participated in the American Association for Cancer Research (AACR) Annual Meetings, held virtually on April 27 - 28, 2020 (Meeting I) and June 22 - 24, 2020 (Meeting II), including presenting the following research results from PREVENT and Early Phase Clinical Projects… Learn more
POSTED: 4/29/2020
An open bottle of Vitamin D on a table with eggs, fish, and vegetables.
This issue reveals there is no association between vitamin D supplementation and colorectal adenomas or polyps risk, that SAHA and EGCG promote apoptosis in breast cancer, and how the metabolome changes in colorectal cancer… Learn more
POSTED: 4/23/2020
A nurse administers the HPV vaccine to a participant in the NCI-funded Costa Rica HPV Vaccine Trial.
More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the vaccine, HPV16 and 18. The new findings are from an extended follow-up of the… Learn more
POSTED: 4/10/2020
An older woman reading a tablet.
Women undergoing radiation therapy for cervical or uterine cancer have a much higher incidence of serious side effects than previously realized, according to results from a new clinical trial. This information may help women and their clinicians more accurately weigh the potential benefits versus… Learn more
POSTED: 4/8/2020
An illustration displaying the experimental drug BAI1 (yellow) which inhibits the BAX protein using a novel binding site (green) and prevents the death of heart cells.
The chemotherapy drug doxorubicin is used to treat many types of cancer, but some patients who receive the drug develop heart problems. Using new insights into how doxorubicin damages the heart, researchers have identified an experimental drug that may help protect the heart.
POSTED: 4/6/2020